APA

Nagashima K. A., Thompson D. A., Rosenfield S. I., Maddon P. J., Dragic T. & Olson W. C. (20010510). Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. : The Journal of infectious diseases.

Chicago

Nagashima K A, Thompson D A, Rosenfield S I, Maddon P J, Dragic T and Olson W C. 20010510. Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. : The Journal of infectious diseases.

Harvard

Nagashima K. A., Thompson D. A., Rosenfield S. I., Maddon P. J., Dragic T. and Olson W. C. (20010510). Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. : The Journal of infectious diseases.

MLA

Nagashima K A, Thompson D A, Rosenfield S I, Maddon P J, Dragic T and Olson W C. Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. : The Journal of infectious diseases. 20010510.